NeuroPace (NPCE) Change in Receivables (2020 - 2026)
NeuroPace (NPCE) posted Change in Receivables of $141000.0 for Q2 2026, up 30.56% on a QoQ basis from $108000.0 in Q1 2026, and up 107.5% year-over-year from $67953.1 in Q2 2025.
Powered by 
Analysis
NeuroPace (NPCE) Change in Receivables (2020 - 2026) Analysis & Trends
NeuroPace has reported Change in Receivables for 7 years, with the latest figure at $141000.0 in Q2 2026.
- On a quarterly basis, Change in Receivables rose 107.5% year-over-year to $141000.0 in Q2 2026; TTM through Jun 2026 was $1.4 million, a 40.5% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, up 241.42% from the prior year.
- Change in Receivables was $141000.0 for Q2 2026 at NeuroPace, up from $108000.0 in the prior quarter.
- The five-year high for Change in Receivables was $2.6 million in Q1 2025, with the low at -$1.9 million in Q2 2025.
- Average Change in Receivables over 5 years is $436444.4, with a median of $229500.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables surged 1115.46% in 2022, then plunged 383.55% in 2025.
- Over 5 years, Change in Receivables stood at -$392000.0 in 2022, then jumped by 368.37% to $1.1 million in 2023, then advanced by 22.53% to $1.3 million in 2024, then tumbled by 119.94% to -$257000.0 in 2025, then surged by 154.86% to $141000.0 in 2026.
- The last three Change in Receivables figures came in at $141000.0 (Q2 2026), $108000.0 (Q1 2026), and -$257000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -90.00 Mn |
| 10 | NeuroPace | 493.15 Mn | 441.45 Mn | 18.91 Mn | 141,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 141,000.00 |
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | -257,000.00 |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | -1.88 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 318,000.00 |
| Jun 30, 2024 | -389,000.00 |
| Mar 31, 2024 | -682,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 403,000.00 |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.71 Mn |
| Dec 31, 2022 | -392,000.00 |
| Sep 30, 2022 | -601,000.00 |
| Jun 30, 2022 | -586,000.00 |
| Mar 31, 2022 | 1.97 Mn |
| Dec 31, 2021 | 480,000.00 |
| Sep 30, 2021 | -1.09 Mn |